Viewing Study NCT02213861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2026-01-24 @ 2:15 PM
Study NCT ID: NCT02213861
Status: UNKNOWN
Last Update Posted: 2016-10-20
First Post: 2014-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma
Sponsor: TetraLogic Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous T-Cell Lymphoma (CTCL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CTCL View
None Cutaneous T-Cell Lymphoma View
None Early-stage View
None SHAPE View
None SHP-141 View
None topical View
None Histone deacetylase inhibitor View
None CAILS View
None mSWAT View
None mycosis fungoides View